Clinical Trial Restart Resource Toolkit

This toolkit provides a collection of best practices, considerations, and resources for clinical trial conduct in the face of the COVID-19 pandemic. The aim of this toolkit is to provide guidance for sites and sponsors that are looking to restart clinical trials during a pandemic. Many of the strategies and tools provided have been implemented in sites across Ontario.

 

About this resource:

Clinical trial activity in Ontario, and worldwide, has been impacted by the COVID-19 pandemic. Since the onset of the pandemic, clinical trial sites and sponsors have been tasked with the challenge of conducting clinical trials safely in our new reality. CTO took on the role of supporting our community through this challenging time by facilitating a cross-stakeholder working group to establish best practices and harmonized solutions for Ontario’s clinical trials community. CTO thanks the key stakeholders from sites, sponsors and CROs who contributed to this resource. In working with the community, five topic areas were recognized as essential for clinical trial restart: pandemic management, on-site visits, remote data monitoring, eConsent, and remote consent. To explore each topic area, click on the icons below.

This is a live resource. We recognize that additional resources and best practices may exist. If you would like to contribute to the toolkit please email Linnea Aasen-Johnston or Andrew Haller.